These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7539076)

  • 1. Inhibition of HIV-1 reverse transcriptase by defined template/primer DNA oligonucleotides: effect of template length and binding characteristics.
    Idriss H; Stammers DK
    J Enzyme Inhib; 1994; 8(2):97-112. PubMed ID: 7539076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction.
    Arts EJ; Li X; Gu Z; Kleiman L; Parniak MA; Wainberg MA
    J Biol Chem; 1994 May; 269(20):14672-80. PubMed ID: 7514178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity labeling and functional analysis of the primer binding domain of HIV-1 reverse transcriptase.
    Andreola ML; Tarrago-Litvak L; Levina AS; Kolocheva TI; el Dirani-Diab R; Jamkovoy VI; Khalimskaya NL; Barr PJ; Litvak S; Nevinsky GA
    Biochemistry; 1993 Apr; 32(14):3629-37. PubMed ID: 7682110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain.
    Wu J; Amandoron E; Li X; Wainberg MA; Parniak MA
    J Biol Chem; 1993 May; 268(14):9980-5. PubMed ID: 7683687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
    Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML
    Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribonuclease H activity during initiation of reverse transcription using tRNA(lys)/RNA primer/template of human immunodeficiency virus.
    Artzi HB; Shemesh J; Zeelon E; Amit B; Kleiman L; Gorecki M; Panet A
    Arch Biochem Biophys; 1996 Jan; 325(2):209-16. PubMed ID: 8561499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.
    Thrall SH; Reinstein J; Wöhrl BM; Goody RS
    Biochemistry; 1996 Apr; 35(14):4609-18. PubMed ID: 8605212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
    Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
    J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptase.
    Althaus IW; Chou KC; Lemay RJ; Franks KM; Deibel MR; Kezdy FJ; Resnick L; Busso ME; So AG; Downey KM; Romero DL; Thomas RC; Aristoff PA; Tarpley WG; Reusser F
    Biochem Pharmacol; 1996 Mar; 51(6):743-50. PubMed ID: 8602869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by 3'-blocked oligonucleotide primers.
    Austermann S; Kruhøffer M; Grosse F
    Biochem Pharmacol; 1992 Jun; 43(12):2581-9. PubMed ID: 1378738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel single-stranded DNA enzyme expression system using HIV-1 reverse transcriptase.
    Kusunoki A; Miyano-Kurosaki N; Takaku H
    Biochem Biophys Res Commun; 2003 Feb; 301(2):535-9. PubMed ID: 12565895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses.
    Ren J; Diprose J; Warren J; Esnouf RM; Bird LE; Ikemizu S; Slater M; Milton J; Balzarini J; Stuart DI; Stammers DK
    J Biol Chem; 2000 Feb; 275(8):5633-9. PubMed ID: 10681546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.
    Patel PH; Jacobo-Molina A; Ding J; Tantillo C; Clark AD; Raag R; Nanni RG; Hughes SH; Arnold E
    Biochemistry; 1995 Apr; 34(16):5351-63. PubMed ID: 7537090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of antisense oligonucleotides on human immunodeficiency virus type 1 reverse transcription.
    Bordier B; Hélène C; Barr PJ; Litvak S; Sarih-Cottin L
    Nucleic Acids Res; 1992 Nov; 20(22):5999-6006. PubMed ID: 1281317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-affinity interaction of human immunodeficiency virus type-1 reverse transcriptase with partially complementary primers.
    Zakharova OD; Tarrago-Litvak L; Maksakova G; Andréola ML; Dufour E; Litvak S; Nevinsky GA
    Eur J Biochem; 1995 Nov; 233(3):856-63. PubMed ID: 8521851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.
    Filipowsky ME; Kopka ML; Brazil-Zison M; Lown JW; Dickerson RE
    Biochemistry; 1996 Dec; 35(48):15397-410. PubMed ID: 8952492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells.
    Bordier B; Perala-Heape M; Degols G; Lebleu B; Litvak S; Sarih-Cottin L; Hélène C
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9383-7. PubMed ID: 7568137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse transcriptase from human immunodeficiency virus: a single template-primer binding site serves two physically separable catalytic functions.
    Krug MS; Berger SL
    Biochemistry; 1991 Nov; 30(44):10614-23. PubMed ID: 1718423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 reverse transcriptase shows no specificity for the binding of primer tRNA(Lys3).
    Arion D; Harada R; Li X; Wainberg MA; Parniak MA
    Biochem Biophys Res Commun; 1996 Aug; 225(3):839-43. PubMed ID: 8780699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.